⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

June 21, 2024Cancer BiomarkersOpen Access

Rho GTPase-activating protein 4 is upregulated in Kidney Renal Clear Cell Carcinoma and associated with poor prognosis and immune infiltration

Xuesong Xiao Xiaofei Lv Tianyu Lin Jianqiao Li Rui Wang Shaoping Tian Xinyu Liu Shiming Liu Huamao Jiang Dan Yue Yong Wang

View Full Paper

Ask AI

Bookmark

Share

Abstract

Kidney Renal Clear Cell Carcinoma (KIRC) is a malignant tumor that seriously threatens human health. Rho GTPase-activating protein 4 (ARHGAP4) plays an important role in the occurrence and development of tumors.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Xiao et al. (2024) studied this question.

synapsesocial.com/papers/68e63d1bb6db6435875cf0fe https://doi.org/10.3233/cbm-230388

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1ARHGAP4/MYH9/β-catenin/c-Jun positive feedback loop promotes colorectal cancer stemness2025 · 1 citations
2ARHGAP40 suppresses clear cell renal cell carcinoma progression and is associated with altered glutamine-related metabolism and redox balanceOriginal Research · 2026
3<scp>CPA4</scp> as a biomarker promotes the proliferation, migration and metastasis of clear cell renal cell carcinoma cells2024 · 12 citations
4Reduced HMGCR Expression in Clear Cell Renal Cell Carcinoma Is Associated With Poor Patient Prognosis.Original Research · 2026
5Multi-omics and experimental validation identify RAPGEF2 as a protective prognostic biomarker in clear cell renal cell carcinomaOriginal Research · 2026